Project Details
Description
Objective 1. To determine the effect and dose-response relationship of SGE516 treatment on hyperthermia-induced seizures in Scn1a+/- Dravet mice and wild-type littermates.
Objective 2. To determine the effect and dose-dependence of SGE516 treatment on survival of Scn1a+/- Dravet mice and wild-type littermates.
Status | Finished |
---|---|
Effective start/end date | 12/17/14 → 6/17/16 |
Funding
- Sage Therapeutics, Inc. (Agmt 1/5/15)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.